Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Biogen (United Kingdom) | Researchclopedia

Back to institutions

Biogen (United Kingdom)

Maidenheadcompany

234

Works

8,073

Citations

42

h-index

Top Research Topics

Biosimilars and Bioanalytical Methods Multiple Sclerosis Research Studies Neurogenetic and Muscular Disorders Research

Top Researchers

Anthony E. Lang University of Toronto

1,543 works140,464 citationsh-index: 166

Recent Research

Unlocking the potential of disease prevention through regulatory science

Daniel J. O’Connor,Alison C. Cave,et al.

20260 citations

Health Systems, Economic Evaluations, Quality of Life

Pharmaceutical studies and practices

RNA modifications and cancer

Acute Lymphoblastic Leukemia research

Rheumatoid Arthritis Research and Therapies

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Congenital Anomalies and Fetal Surgery

Monoclonal and Polyclonal Antibodies Research

Systemic Sclerosis and Related Diseases

Brit Mollenhauer Nephrologisches Zentrum Goettingen

473 works39,293 citationsh-index: 90

Yoram Bouhnik Clinique Ambroise Paré

575 works26,139 citationsh-index: 90

Andrew L. Clark University of Bedfordshire

720 works22,792 citationsh-index: 73

Colin Green National Institutes of Health

429 works19,019 citationsh-index: 70

David W. Miller Murdoch University

385 works18,812 citationsh-index: 63

High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial

Richard S. Finkel,Thomas O. Crawford,et al.

20260 citations

Long-Term Tofersen in <i>SOD1</i> Amyotrophic Lateral Sclerosis

Timothy M. Miller,Merit Cudkowicz,et al.

20261 citations

Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy

Crystal M. Proud,Richard S. Finkel,et al.

20254 citations

422PNURTURE study: long-term benefits of nusinersen in presymptomatic spinal muscular atrophy (SMA) over 8 years of Follow-up

N. Kuntz,D. De Vivo,et al.

20250 citations

24ODEVOTE part C results: exploring higher doses of nusinersen in nusinersen-experienced participants with spinal muscular atrophy (SMA)

E. Mercuri,Thomas O. Crawford,et al.

20250 citations